Sort
21,281 grants matching “influenza”
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$297,402Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2023 · TW
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$297,388Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2024 · TW
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$297,374Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2025 · TW
GENETIC CONTROL OF NITRATE RESPIRATION IN E COLI
$297,371University Of California Davis · R01 · FY2001 · GM
Influence of Age on CD4 T Memory Cells
$297,368Jorg J Goronzy · Palo Alto Veterans Instit For Research · R01 · FY2017 · AG
In Vitro /In Vivo Approach to Artery Wall Inflammation
$297,335University Of California Los Angeles · P01 · FY2003 · HL
Pulmonary delivery of a hybrid therapeutic to halt respiratory viral infection
$297,333Joy A Phillips · San Diego State University · R01 · FY2014 · GM
Selective fluorescent labeling of proteins in living cells
$297,297Sanford M Simon · Rockefeller University · R01 · FY2010 · GM
Examining the role of cellular miRNAs in HIV-1 Replication
$297,263Chandravanu Dash · Meharry Medical College · U54 · FY2021 · MD
Discovery of a Novel Promoter in Pathogenic Influenza
$297,205Wadsworth Center · R21 · FY2005 · AI
Large scale in vitro production of capped polyadenylated mRNA-based vaccines in solid phase using immobilized enzymes
$297,193Maria Kireeva · Affinity Molecules, Llc · R43 · FY2021 · TR
Preclinical Studies of Vaccines for Pandemic Influenza
$297,079Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Immune molecules and synaptic connectivity in maternal immune activation offspring and schizophrenia
$297,028A Kimberley McAllister · University Of California At Davis · P50 · FY2016 · MH
An improved mouse model for aging immunology
$297,000Marcia A Blackman · Trudeau Institute, Inc. · R21 · FY2017 · AG
Transmissibility of Influenza A Viruses
$297,000University Of Maryland College Pk Campus · R01 · FY2005 · AI
Novel antiviral strategy offering forward capability and reduced risk of escape
$297,000Andrew Hayhurst · Texas Biomedical Research Institute · R21 · FY2023 · AI
Cytokine regulation of memory CD8 T cell responses
$297,000Kimberly D. Klonowski · University Of Georgia · R01 · FY2009 · AI
Characterization of Cross-Reactive Immune Responses Against Influenza Virus Surf
$296,983Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
Influence of Age on CD4 T Memory Cells
$296,948Jorg J Goronzy · Palo Alto Veterans Instit For Research · R01 · FY2014 · AG
Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses
$296,935Patricia Veronica Aguilar · University Of Texas Med Br Galveston · D43 · FY2022 · TW
New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists
$296,931Barry A Berkowitz · Bessor Pharma, Llc · R43 · FY2024 · AI
Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury
$296,926Brian J. Akerley · Advac Therapeutic, Llc · R41 · FY2022 · AI
Exploring the mechanistic basis for altered peripheral B cell selection in SLE
$296,899Patrick Christopher Wilson · University Of Chicago · U19 · FY2017 · AI
Discovery of small molecules to block fusion and entry of dengue and other env vi
$296,883Stephen C Harrison · Harvard Medical School · U54 · FY2009 · AI
Studies on Protein Lipidation
$296,766Howard C Hang · Scripps Research Institute, The · R01 · FY2021 · GM